drug · small molecule
patient view →nintedanib
Phase 3updated 2mo agoby Cloudbreak Therapeutics LLC🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 33 investigational indications.
indications
indications
Pulmonary Fibrosis
targets
Platelet-derived growth factor receptorVascular endothelial growth factor receptorFibroblast growth factor receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that